SCHEMBL29732893

SCHEMBL29732893

CCCCCCCCCCCCCCCCc1ccnc(N2CCC2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.47
▸ ADRB2 P07550 2/20 0.44
▸ ADRB1 P08588 2/20 0.44
▸ ADRB3 P13945 2/20 0.44
▸ HTR1A P08908 1/20 0.43
▸ DRD2 P14416 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ HTR7 P34969 1/20 0.43
▸ HTR6 P50406 1/20 0.43
▸ ACHE P22303 6/20 0.39
▸ DYRK1A Q13627 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ACACB O00763 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29732724 1.00 KCNH2 (0.47) KCNH2ADRB2ADRB1ADRB3HTR1A
SCHEMBL5330907 0.86 CETP (0.49) KCNH2ADRB2ADRB1ADRB3HTR1A
Hydrochloric Acid SCHEMBL8880842 0.80 CETP (0.52) ADRB2ADRB1HTR1ADRD2HTR2A
SCHEMBL21715629 0.78 ACHE (0.47) HTR1ADRD2HTR2AHTR7HTR6
SCHEMBL23781493 0.77 CASP1 (0.44) KCNH2HTR1ADRD2HTR2AHTR7
SCHEMBL23781494 0.77 CASP1 (0.44) KCNH2HTR1ADRD2HTR2AHTR7
SCHEMBL18029912 0.77 ALDH1A1 (0.44) KCNH2HTR1ADRD2HTR2AHTR7
SCHEMBL24331778 0.77 DRD2 (0.43) KCNH2HTR1ADRD2HTR2AHTR7
SCHEMBL15599258 0.76 ACHE (0.46) HTR1ADRD2HTR2AHTR7HTR6
SCHEMBL12844623 0.76 ACHE (0.50) ACHEMAPTKDM4EACACBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11390605-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2022-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11390605-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses DPYD, TYMP, NUDT1 KCNH2 2329/4885ADRB2 2023/4885ADRB1 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback